Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endometrial Cancer: Evaluation of Genetic Imbalances in the Carcinogenesis Process

NCT02833896 is registered in ClinicalTrials.gov with CHU de Reims as lead sponsor.

NCT NCT02833896
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02833896 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endometrial Cancer: Evaluation of Genetic Imbalances in the Carcinogenesis Process
Lead sponsor
CHU de Reims
Phase
Observational
Overall status
Completed
Start date
November 30, 2010
Completion date
March 31, 2016
Enrollment
95 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of the endometrium